TRAVERE THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 61117000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/373cea1c-8729-436e-ba87-2b8cbf586553
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-18-000016Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/cash-and-equivalents/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/373cea1c-8729-436e-ba87-2b8cbf586553
History
- no predecessors — first report